Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Conduit Pharmaceuticals ( (CDT) ) has shared an announcement.
On May 5, 2025, Conduit Pharmaceuticals Inc. held a special meeting of stockholders where a quorum was achieved with proxies representing over one-third of the company’s common stock. During the meeting, stockholders approved amendments to the company’s Certificate of Incorporation to allow for reverse stock splits at ratios determined by the board of directors. This decision could potentially impact the company’s stock structure and market perception.
More about Conduit Pharmaceuticals
Average Trading Volume: 5,766,367
Technical Sentiment Signal: Sell
Current Market Cap: $6.09M
Learn more about CDT stock on TipRanks’ Stock Analysis page.